(73 days)
Not Found
Not Found
No
The summary describes a standard RF coagulation system with a catheter, generator, and return electrode. There is no mention of AI, ML, image processing, or any data analysis that would suggest the use of such technologies. The performance studies focus on functional and electrical testing, not algorithmic performance.
Yes
The device is intended for coagulation or hemostasis (arrest of bleeding), which are therapeutic actions to treat a condition in the tracheobronchial tree.
No
The device is described as being used for coagulation or hemostasis, which are therapeutic interventions, not diagnostic ones. It delivers RF energy to a target site rather than collecting information for diagnosis.
No
The device description explicitly lists hardware components: a catheter, an RF generator, and a patient return electrode.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information about a person's health. This testing is done outside of the body (in vitro).
- Broncus Coagulation Electrode System Function: The description clearly states the device is used for "coagulation or hemostasis in the tracheobronchial tree." This is a therapeutic procedure performed directly on the patient's tissue within the body (in vivo). It's not analyzing a sample taken from the body.
The device is an electrosurgical system used for therapeutic purposes, not for diagnostic testing of samples.
N/A
Intended Use / Indications for Use
The Broncus™ Coagulation Electrode System is intended for coagulation or hemostasis in the tracheobronchial tree.
Product codes (comma separated list FDA assigned to the subject device)
874.4680, 77EOQ, 878.4400, 79GEI
Device Description
The Broncus Coagulation Electrode System consists of a catheter, a RF generator, and a commercially available patient return electrode. The RF generator produces RF power in a monopolar mode. The catheter delivers RF energy to the desired target site and relays temperature and other feedback to the RF generator. The patient return electrode is used to complete the return path for the electrical current.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
tracheobronchial tree
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Coagulation Electrode System has undergone and passed functional and electrical testing designed to assess the performance of the catheter and the RF generator.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 874.4680 Bronchoscope (flexible or rigid) and accessories.
(a)
Identification. A bronchoscope (flexible or rigid) and accessories is a tubular endoscopic device with any of a group of accessory devices which attach to the bronchoscope and is intended to examine or treat the larynx and tracheobronchial tree. It is typically used with a fiberoptic light source and carrier to provide illumination. The device is made of materials such as stainless steel or flexible plastic. This generic type of device includes the rigid ventilating bronchoscope, rigid nonventilating bronchoscope, nonrigid bronchoscope, laryngeal-bronchial telescope, flexible foreign body claw, bronchoscope tubing, flexible biopsy forceps, rigid biopsy curette, flexible biopsy brush, rigid biopsy forceps, flexible biopsy curette, and rigid bronchoscope aspirating tube, but excludes the fiberoptic light source and carrier.(b)
Classification. Class II.
0
JAN 2 8 2000
510(k) Summary of Safety and Effectiveness
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
The assigned 510(k) number is: K993700
Applicant Information:
Date Prepared:
January 17, 2000
Name: Address: Broncus Technologies, Inc. 1400 N. Shoreline Boulevard Building A. Suite 8 Mountain View, CA 94043
Contact Person: Phone Number: Fax Number:
John D'Angelo (650) 428-1600 ext. 312 (650) 428-1542
Device Information:
| Classification | Class II |
|---|---|
| Trade Name: | Broncus™ Coagulation Electrode System |
| Classification Name: | Bronchoscope and Accessories 21 CFR 874.4680 |
Equivalent Devices:
The subject device is substantially equivalent in intended use and/or method of operation to the following predicate devices:
| Broncus Technologies, Inc. | Broncus™ Bronchial Catheter System |
|---|---|
| Olympus America Inc. | Coagulation Electrode |
| Valleylab, Inc. | Force 2 Electrosurgical Generator |
Description:
The Broncus Coagulation Electrode System consists of a catheter, a RF generator, and a commercially available patient return electrode. The RF generator produces RF power in a monopolar mode. The catheter delivers RF energy to the desired target site and relays temperature and other feedback to the RF generator. The patient return electrode is used to complete the return path for the electrical current.
Intended Use:
The Broncus Coagulation Electrode System is intended for coagulation or hemostasis in the tracheobronchial tree.
1
510(k) Summary of Safety and Effectiveness, continued
Comparison to Predicate Devices:
The Broncus Coagulation Electrode System is substantially equivalent in intended use and/or method of operation to the named predicate devices.
Non-Clinical Test Results:
Performance
The Coagulation Electrode System has undergone and passed functional and electrical testing designed to assess the performance of the catheter and the RF generator.
Biocompatibility
The materials used in the Coagulation Electrode have proven biocompatibility.
Summary of Substantial Equivalence:
Based on the intended use and the product performance information provided in this notification, the subject device has been shown to be substantially equivalent to the currently marketed predicate devices.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or a bird in flight, composed of three human profiles facing to the right.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 2 8 2000
Mr. John D'Angelo President and CEO Broncus Technologies, Inc. 1400 N. Shoreline Blvd. Building A, Suite 8 Mountain View, CA 94043
Re: K993900
Trade Name: Coagulation Electrode, Model 2000; Radiofrequency Generator Regulatory Class: Class II Product Code: 874.4680, 77EOQ and 878.4400, 79GEI Dated: November 15, 1999 Received: November 16, 1999
Dear Mr. D'Angelo:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 -- Mr. John D'Angelo
· This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
A Roerl Rosenthal
A. Ralph Rosenthal, M.D. Director Division of Ophthalmic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known):
Device Name:
Broncus™ Coagulation Electrode System
Indications for Use:
The Broncus™ Coagulation Electrode System is intended for coagulation or hemostasis in the tracheobronchial tree.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
OR Over- The Counter Use
(Per 21 CFR 801.109)
(Optional Format 1-2-96)
Karen A. Bohr
(Division Sign-Off)
(Division Sign-Off)
Division of Ophthalmic Devices
510(k) Number 2493470